|
|
|
Click Here to return To Results
|
|
In patients with trigeminal neuralgia (TN), routine head imaging identifies structural causes in up to 15% of patients and may be considered useful (level C). Trigeminal sensory deficits, bilateral involvement of the trigeminal nerve, and abnormal trigeminal reflexes are associated with an increase risk of symptomatic TN (STN) and should be considered useful in distinguishing STN from classic trigeminal neuralgia (level B). There is insufficient evidence to support or refute the usefulness of MRI to identify neurovascular compression of the trigeminal nerve (level U). Carbamazepine (level A) or oxcarbazepine (level B) should be offered for pain control while baclofen and lamotrigine (level C) may be considered useful For patients with TN refractory to medical therapy, Gasserian ganglion percutaneous techniques, gamma knife, and microvascular decompression may be considered (level C). The role of surgery vs pharmacotherapy in the management of TN in patients with MS remains uncertain. |
|
(click to filter results - removes previous filter)
baclofen carbamazepine complications cranial nerves,vascular compression electrocoagulation evidence-based research facial pain gamma knife therapy lamotrigine MRI MRI,abnormal MRI,indications for neurologic disease,diagnoses of practice guidelines review article rhizotomy treatment of neurologic disorder trigeminal neuralgia trigeminal neuralgia,etiology trigeminal neuralgia,pathogenesis of trigeminal neuralgia,surgical treatment of trigeminal neuralgia,treatment of
|
Click Here to return To Results
|
|